School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Maravai LifeSciences Holdings, Inc. MRVI

Healthcare · Biotechnology

$7.44last close 2026-10-09 · market cap $2.76B · delayed data

Trailing returns

1M+7.05%
3M+24.62%
6M+139.23%
1Y+125.45%
5Y-81.80%

Basis: Adjusted daily closes.

What it does

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS.

Open MRVI in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies